Rafferty Asset Management, LLC - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 96 filers reported holding SPERO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$560,000
+61.8%
34,958
+86.1%
0.00%
+50.0%
Q3 2021$346,000
+3.6%
18,789
-21.4%
0.00%0.0%
Q2 2021$334,000
-67.1%
23,898
-65.3%
0.00%
-71.4%
Q1 2021$1,015,00068,9630.01%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders